ClinConnect ClinConnect Logo
Search / Trial NCT06444295

Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault

Launched by UNIVERSITY OF WASHINGTON · May 30, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Sexual Assault Mobile Health Intervention

ClinConnect Summary

This clinical trial is studying the effectiveness of different versions of the THRIVE app, which is designed to help people who have experienced a recent sexual assault. The app aims to reduce issues related to alcohol use and symptoms of posttraumatic stress. Participants in the study will be randomly assigned to use one of the app versions, allowing researchers to compare which one works best.

To participate, you need to be at least 18 years old, fluent in English, and own a smartphone that you can keep private. You must also be a college student and have experienced a sexual assault within the last three months, along with having some issues related to alcohol use and posttraumatic stress. If you join the study, you will have access to the THRIVE app, which is currently only available for research purposes. This is an important opportunity to receive support and help while contributing to valuable research that could benefit others in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Have reached the legal age of majority in their current state of residence
  • Be able to read and speak English fluently
  • Own a smartphone that cannot be accessed by others while the study app is installed, or they agree to take steps to reduce the risk that someone else will access the study app
  • Be an enrolled undergraduate or graduate student at a recruitment site at the time of screening, or if they are on summer break, plan to be enrolled in the upcoming fall term
  • Reside in the same state as the recruitment site for most of the year
  • Have experienced a sexual assault (i.e., unwanted and non-consensual attempted/completed sexual contact) within the past 12 weeks at the time of screening
  • Report ≥1 past-month heavy drinking episode (i.e., 5+ drinks on a given day or 15+ drinks in a given week for participants assigned male at birth and 4+ drinks on a given day or 8+ drinks in a given week for participants assigned female or intersex at birth) at the time of screening
  • Endorse elevated posttraumatic stress symptoms at screening (defined as a score above a pre-established cut point on a screening measure of PTSD).
  • Exclusion Criteria:
  • Active psychosis
  • Location outside of the US at the time of screening

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Emily Dworkin, PhD

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported